Business Wire

CA-DENODO

22.5.2024 13:01:32 CEST | Business Wire | Press release

Share
Denodo Redoubles Focus on Energy and Utilities

Denodo, a leader in data management, announced that the company is expanding its efforts to provide energy and utility companies with the necessary data management capabilities to gain advanced capabilities and meet new renewable energy requirements, all while remaining in compliance with increasingly stringent regulatory demands.

Facing numerous challenges, including generating, managing, and consuming new, decarbonized and increasingly digitized sources of energy; maintaining resilience and sustainability in a time of change; developing new technologies such as virtual power plants (VPPs) based on intelligent operations; all while managing a rising number of environmental, social, and governance (ESG) and sustainability initiatives; energy and utility companies need to be able to manage data so that it helps to overcome these challenges, rather than adding to them.

The Denodo Platform facilitates this by providing real-time access to data across myriad distributed energy resources, while enabling the establishment of a unified semantic layer over all data sources, to deliver data when it is needed, in the language required by each data consumer. This provides energy and utility companies with the foundation to overcome myriad known and unknown challenges. The Denodo Platform enables such capabilities as continuous monitoring and control, and makes it possible for VPP operators to make fast, informed decisions in response to changes in energy demand, pricing, and environmental conditions. By enabling such capabilities, the Denodo Platform provides energy and utility companies with a reliable foundation for innovation.

Denodo has a strong heritage in providing impactful data management solutions to energy and utility companies, such as VTTI, a Netherlands-based energy storage and developer of critical energy infrastructure; BHP, a global resources company headquartered in Melbourne, Australia; Engie Mexico, an energy company that is committed to bringing energy to the people of Mexico; and Suez, a French multinational corporation with operations in water, electricity, natural gas supply, and waste management.

Hans Geurts, chief information officer for VTTI, says, “As a rapidly growing organization in an uncertain geopolitical environment, laying a strong data foundation was critical for us to become data-driven. The Denodo Platform has helped us in simplifying and standardizing our data infrastructure, while boosting our business resilience.” The Denodo Platform acts as VTTI’s single source of truth for enterprise resource planning (ERP) data. The company leverages it to synthesize, combine, and analyze operational insights to improve ways of working and address inefficiencies in the operational micro-steps at the company’s terminals. It also helps VTTI to visualize and understand product trade flows through the terminals and various modes of transport, helping VTTI’s commercial teams to better serve customers.

Joshua Fletcher, superintendent HSE, Reporting at BHP, made similar statements about the effect that the Denodo Platform had on the company’s business. “The Denodo Platform helps us to reduce the overall size of the data sets that need to be moved over the network. It helped us to create a logical data fabric that makes our data assets reusable and can be consumed by users spread across the globe.”

Luis Guadarrama, senior manager, Data Analytics and Innovation at Engie Mexico, says, “The Denodo Platform delivers data quickly and easily, which helps us to deliver value to the business and democratize data access. Our business users might not understand the technical part, but they do understand that there’s something called ‘the Denodo Platform’ that helps them to connect to data in an easier way, to make better decisions.” Engie Mexico leveraged the Denodo Platform to enable a variety of strategic initiatives, including web services that help hundreds of thousands of customers to balance their use of natural gas, chatbots that assist in problem resolution, and machine learning (ML) algorithms that analyze the behavior patterns of business-to-consumer gas customers.

Denodo believes that VPPs are the power plants of the future. VPPs can run energy in the cloud, and they can supply renewable energy on-demand, through innovative web-based interfaces that can remotely link and manage homes with solar and battery storage. Additionally, VPPs can feed power back to the grid during peak times, to relieve the load and keep the network stable.

Denodo also believes that data-driven, intelligent operations is a critical capability that can greatly assist utility CIOs in designing fit-for-the-future assets that bridge physical and digital phenomena. The Denodo Platform facilitates the development of intelligent operations and VPPs through diverse capabilities, including distributed energy resource management, predictive analytics for maintenance, and optimization of energy assets.

“Advanced data management technology will be essential in enabling new capabilities that oil and gas companies need to thrive, both now and beyond the energy transition,” said Paul Moxon, SVP Data Architecture and Chief Evangelist at Denodo. “Power plants of the future will operate in an eco-centric, distributed manner, enabling the data-driven, intelligent VPPs of the future. The Denodo Platform, with its ability to provide real-time data access to increasingly diverse data sources, will underpin success by providing energy and utility business users with access to data at the speed of business.”

For more information:

About Denodo

Denodo is a leader in data management. The award-winning Denodo Platform is the leading logical data management platform for delivering data in the language of business, at the speed of business, for all data-related initiatives across the organization. Realizing more than 400% ROI and millions of dollars in benefits, Denodo’s customers across enterprises in 30+ industries all over the world have received payback in less than six months. For more information, visit denodo.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522149387/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release

Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye